Revision summary
TKDL puts classical Indian medical texts in a form patent examiners can search, so claims fail for lack of novelty. The Patents Act excludes traditional knowledge as such and limits evergreening of known substances. The Biological Diversity Act requires approval and benefit-sharing for many uses of Indian bio-resources and associated knowledge. Turmeric, neem, and Basmati disputes showed why a defensive library was built. Undocumented folk knowledge and a fair commercial share remain weaker than the patent shield.
Model answer
Copper italics in this answer — like this — are the key facts. Each one is unpacked in the Facts & figures rail.
Introduction
Indian medicine — Ayurveda, Siddha, Unani, Yoga, folk healing — is old public knowledge. A firm that patents a turmeric wound use or a neem extract as a “new invention” can lock others out. India fights that with a defensive database, with what the Patents Act refuses to grant, and with biodiversity access rules. The aim is not to stop honest research. It is to stop biopiracy: private monopoly over what communities already knew.
Body
Traditional Knowledge Digital Library (TKDL)
- TKDL is a joint Council of Scientific and Industrial Research (CSIR) and Ministry of AYUSH project. It transcribes formulations from classical texts into structured, searchable, multilingual records (including patent-examiner languages).
- India has access agreements with major patent offices (including the European Patent Office and others) so examiners can find prior art and refuse or narrow claims.
- This is defensive publication: the knowledge is documented so it is not “novel”. It does not by itself pay the village that kept the plant.
- Documented wins after earlier disputes: turmeric (wound healing), neem (fungicidal properties), and Basmati rice lines were fought in foreign offices; TKDL was built so the next examiner sees the text before a grant.
Patent law inside India
- Patents Act, 1970 (as amended): section 3(p) excludes an invention which in effect is traditional knowledge or an aggregation of known properties of traditionally known components.
- Section 3(d) blocks evergreening of known substances unless there is a new therapeutic efficacy — relevant when a firm slightly modifies a known plant isolate.
- Section 3(e) and other clauses limit mere admixtures. Pre-grant and post-grant opposition let CSIR, AYUSH, or public-interest groups challenge a claim.
- Disclosure of biological material and geographical origin in the application supports examination.
Biodiversity and community tools
- Biological Diversity Act, 2002: National Biodiversity Authority and State boards regulate access to Indian biological resources and associated knowledge; prior approval and benefit-sharing are required for certain research, patents, and commercial use, especially involving foreigners or specified firms.
- People’s Biodiversity Registers record local knowledge at panchayat scale — a grassroots prior-art layer if they are actually maintained.
- Geographical Indications (for example on some agricultural and traditional goods) protect names, not medical formulae, but they stop a foreign brand from capturing a place-linked product.
- Nagoya Protocol on access and benefit-sharing sits behind the same logic internationally.
Institutions and positive protection
- Ministry of AYUSH, pharmacopoeias, and research councils (CCRAS and others) standardise and clinically test, so the knowledge can be used as a public system, not only as a patent shield.
- Yoga and some well-known practices were also the target of foreign patent attempts; documentation and diplomatic protest were the response.
Limits and recommendations
- TKDL covers codified classical texts better than undocumented tribal medicine. Expand community registers with consent and benefit-sharing, not extraction.
- Defensive protection stops a bad patent; it does not create an Indian product or a royalty for the holder of the knowledge. Pair TKDL with NBA contracts and public-sector formulation brands.
- Watch evergreening of isolates and process patents that skirt 3(p).
- Harmonise speed of NBA clearance so genuine research is not driven underground while pirates still file abroad.
- Train more examiners on TKDL and keep the library updated in more languages and oral traditions (with ethics).
Flow diagram
Conclusion
India protects traditional medical knowledge mainly by TKDL prior art in foreign and Indian examination, by Patents Act exclusions such as section 3(p), by Biodiversity Act access and benefit-sharing, and by AYUSH documentation. Turmeric and neem taught the cost of arriving late. The remaining gap is undocumented community knowledge and a fair share when a real product is made — not only a refused patent.
Quick related
Students also ask
-
Examine the role of supermarkets in supply chain management of fruits, vegetables and food items. How do they eliminate number of intermediaries? (150 Words, 10 Marks).
Next question on this syllabus topic (2018 · Q4). View answer →
-
Does TKDL mean nobody can research Ayurvedic plants?
No. It means you cannot patent what the texts already teach. New, inventive, legally obtained work can still be filed, subject to biodiversity rules.
-
If a patent is refused, does the community get money?
Not from the refusal alone. Money requires a benefit-sharing agreement under the Biodiversity Act when a commercial product is actually made.
Same topic · past papers
UPSC has asked this before
These previous-year questions sit on the same topic. Open one to practise the earlier ask.
More from this topic
Q17 · UPSC Mains 2026 · GS III · 15 marks · Solution
What are the challenges to solid waste management in India? Discuss the governmental policy framework on solid waste management. Discuss the success/failure cases of Delhi and Indore cities highlighting the salient features of their solid waste management initiatives.
Indian Economy
• Challenges: volume growth, mixed waste, land, informal exclusion, weak finance. • SWM Rules 2016 mandate segregation, collection, processing, user fees. • Plastic/C&D/e-waste rules and SBM Urban complete the framework. • Swachh Survekshan creates competitive accountability. • Indore: strong segregation, collection, processing, enforcement. • Delhi: huge volumes, legacy dumps, fires, fragmented stress. • Lesson: behaviour + processing beat trucks-only strategies. • Biomining and bulk-generator compliance are essential for metros.
Q16 · UPSC Mains 2026 · GS III · 15 marks · Solution
What is Agentic Artificial Intelligence (AI)? Explain its working. Describe its applications with suitable examples. Discuss the advantages, risks and challenges associated with agentic AI systems.
Indian Economy
• Agentic AI pursues goals via plan–act–observe loops, not one-shot replies. • Working parts: planning, tools, memory, guardrails, stop conditions. • Uses: grievance assist, compliance, agri/disaster fusion, cyber SOCs, tutoring. • Advantages: speed, consistency, expert leverage, continuous monitoring. • Risks: harmful actions from hallucinations, injection attacks, privacy leaks. • India challenges: languages, liability, data law, compute cost, evaluation. • Govern with human approval for high stakes, logs and allow-listed tools. • Sandboxes beat unsupervised autonomy over money and rights.
Q15 · UPSC Mains 2026 · GS III · 15 marks · Solution
Mention salient features of 'Mission Drishti'. Discuss the imaging techniques used in the satellite launched on 3rd May 2026. Why is it being considered world's first satellite of its kind?
Indian Economy
• Mission Drishti is GalaxEye's EO satellite launched 3 May 2026. • Marketed as world's first OptoSAR combining optical + all-weather radar. • Described as India's largest privately built satellite in that category. • Imaging: X-band SAR (Stripmap/Spotlight) plus 7-band MSI. • Fusion on one platform avoids two-satellite parallax/time errors. • Fused resolution marketed near 1.8 m; SAR spotlight finer (~0.9 m claimed). • Orbit: sun-synchronous LEO ~500 km class; revisit ~4 days (company). • Novelty is integrated commercial OptoSAR—not inventing SAR/optical physics.